EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access

Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC‐EHRA EORP Atrial Fibrillation Long‐Term General Registry

Niccolò Bonini iD, Marco Proietti iD, Giulio Francesco Romiti iD, Marco Vitolo iD, Ameenathul Mazaya Fawzy, Wern Yew Ding iD, Jacopo Francesco Imberti iD, Laurent Fauchier iD, Francisco Marin iD, Michael Nabauer, Gheorghe Andrei Dan iD, Tatjana S Potpara iD und 3 weitere

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.123.030499 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Niccolò Bonini und 14 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital Liverpo…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure, Registries, Stroke Volume. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart failure (HF) often occurs in patients with atrial fibrillation (AF), with a major impact on prognosis. Few data are available on the effect of integrated treatment strategies to improve prognosis in patients with AF. We aimed to evaluate the association between HF (according to left ventricular ejection fraction [LVEF]), HF optimal medical therapy and adherence to the Atrial Fibrillation Better Care pathway, and major outcomes in patients with AF. Methods and Results From the ESC‐EHRA EORP‐AF (European Society of Cardiology–European Heart Rhythm Association EURObservational Research Programme in Atrial Fibrillation) General Long‐Term Registry, we evaluated patients with HF, categorized according to LVEF (HF with reduced ejection fraction, HF with mildly reduced ejection fraction, HF with preserved ejection fraction). Optimal medical therapy for HF was guidelines‐defined. The primary end point was the composite of all‐cause death and major adverse cardiovascular events. From the original cohort, 9373 (84.5%) patients were included in this analysis (median age, 71 [interquartile range, 62–77] years; 39.9% women). Compared with no HF, all HF categories were associated with an increased risk of the primary composite outcome, with highest figures observed for HF with reduced ejection fraction (hazard ratio [HR], 2.36 [95% CI, 2.00–2.78]). The risk was reduced in patients with AF and HF adherent to optimal medical therapy (HR, 0.83 [95% CI, 0.70–0.98]), as well as in those adherents to the Atrial Fibrillation Better Care pathway (HR, 0.65 [95% CI, 0.48–0.88]). The effect of Atrial Fibrillation Better Care pathway was consistent across the spectrum of LVEF.

Conclusions

Patients with AF and HF have a high risk of major adverse events, and this risk is inversely associated with LVEF. Atrial Fibrillation Better Care pathway adherent management is associated with improved clinical outcomes in patients with HF, across the spectrum of LVEF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart FailureRegistriesStroke VolumeVentricular Function, LeftHumansFemaleMaleAgedMiddle AgedEuropeTreatment OutcomeGuideline AdherenceDelivery of Health Care, IntegratedTime FactorsRisk Factors

Stichwörter der Autor:innen

atrial fibrillationheart failureintegrated careoutcomes

Autor:innen und Institutionen

  • Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital Liverpool United Kingdom.
  • Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences University of Modena and Reggio Emilia, Policlinico di Modena Modena Italy.
  • Department of Clinical Sciences and Community Health University of Milan Milan Italy.
  • Division of Subacute Care IRCCS Istituti Clinici Scientifici Maugeri Milan Italy.
  • Department of Translational and Precision Medicine Sapienza-University of Rome Italy.
  • Clinical and Experimental Medicine PhD Program University of Modena and Reggio Emilia Modena Italy.

ORCID-Profile: Niccolò Bonini, Marco Proietti, Giulio Francesco Romiti, Marco Vitolo, Wern Yew Ding, Jacopo Francesco Imberti, Laurent Fauchier, Francisco Marin, Gheorghe Andrei Dan, Tatjana S Potpara, Giuseppe Boriani, Gregory Y H Lip

Zitieren

APA

Bonini, N., Proietti, M., Romiti, G. F., Vitolo, M., Fawzy, A. M., Ding, W. Y., Imberti, J. F., Fauchier, L., Marin, F., Nabauer, M., Dan, G. A., Potpara, T. S., Boriani, G., Lip, G. Y. H., & ESC‐EHRA EORP‐AF General Long‐Term Registry Investigators (2025). Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC‐EHRA EORP Atrial Fibrillation Long‐Term General Registry. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.030499

Vancouver

Bonini N, Proietti M, Romiti GF, Vitolo M, Fawzy AM, Ding WY, et al. Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC‐EHRA EORP Atrial Fibrillation Long‐Term General Registry. Journal of the American Heart Association. 2025. doi:10.1161/jaha.123.030499

BibTeX
@article{Bonini2025,
  author = {Bonini, Niccolò and Proietti, Marco and Romiti, Giulio Francesco and Vitolo, Marco and Fawzy, Ameenathul Mazaya and Ding, Wern Yew and Imberti, Jacopo Francesco and Fauchier, Laurent and Marin, Francisco and Nabauer, Michael and Dan, Gheorghe Andrei and Potpara, Tatjana S and Boriani, Giuseppe and Lip, Gregory Y H and ESC‐EHRA EORP‐AF General Long‐Term Registry Investigators, ESC‐EHRA EORP‐AF General Long‐Term Registry Investigators},
  title = {Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC‐EHRA EORP Atrial Fibrillation Long‐Term General Registry},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.123.030499}
}
Kostenlos starten →